Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
Key Information
Due Date: September 1, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: Not Specified
Funding Type: Cooperative Agreement
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The ultimate aim is to finance those medication studies which can have influential results and rapidly provide the necessary evidence to move medications closer to FDA approval. It is anticipated that these grants will be short-term, with funding available for up to three years. The grants are also substantial, with up to $5 million available per year.
These are cooperative agreements that will be carefully monitored and involve significant scientific input from NIDA staff. Furthermore, these grants will facilitate essential studies in medication development, which would otherwise not be possible under the more traditional R01 activity code.
Key Dates
Open Date: September 1, 2022
Application Due Date: September 1, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses